Anavex Life Sciences Corporation/ US0327973006 /
21.05.2024 22:00:00 | Diff. -0,0800 | Volumen | Geld10:03:00 | Brief10:03:00 | Tageshoch | Tagestief |
---|---|---|---|---|---|---|
4,3500USD | -1,81% | 728.903 Umsatz: 2,66 Mio. |
4,2500Geld Vol: 100 | 4,7500Brief Vol: 100 | 4,4769 | 4,3000 |
Newsfile Corp
13:00
Flow Beverage Corp. to Present at Water Tower Research's Inaugural Consumer Products Virtual Investo...
GlobeNewswire
13:00
Entero Therapeutics to Present Corporate Update at 2024 BIO International Convention
GlobeNewswire
13:00
Medicenna to Present Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming Sachs 10th Annual...
GlobeNewswire
13:00
Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-...
GlobeNewswire
13:00
Cartesian Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for De...
GlobeNewswire
13:00
Will AI Make Leaders Obsolete? AIIR Teams Up with Microsoft and Wharton to Consider the Implications
GlobeNewswire
13:00
Atea Pharmaceuticals Presents New Data Showcasing Potential Best-in-Class Combination Profile of Bem...
GlobeNewswire
13:00
Nokia successfully completes acquisition of Fenix Group, accelerating U.S. strategy
GlobeNewswire
12:56
Gate.io Celebrates 11th Anniversary with Prize Activities and Vision for the Future
GlobeNewswire
12:55
Antion Biosciences announces development of safety-enhanced and off-the-shelf CAR T-cells for autoim...
Newsfile Corp
12:36
Early Leak Unveils Exciting Lineup of Speakers and Sponsors for ADFO Summit 2024
- Erste Seite
- Zurück
- 1
- 2
- 3
- 4
- Weiter
- Letzte Seite